SCHEMBL1003604

SCHEMBL1003604

CC(C)(Cc1ccccc1)OC(=O)OC(C)(C)Cc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 1/20 0.49
HIF1A Q16665 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
SLC6A2 P23975 1/20 0.47
TAAR1 Q96RJ0 1/20 0.47
CYP3A4 P08684 4/20 0.45
ALDH1A1 P00352 3/20 0.45
CYP2C19 P33261 3/20 0.45
MMP8 P22894 3/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2D6 P10635 2/20 0.45
RECQL P46063 2/20 0.45
CYP1A2 P05177 2/20 0.45
NFKB1 P19838 1/20 0.45
PPARG P37231 1/20 0.45
PPARA Q07869 1/20 0.45
LMNA P02545 2/20 0.44
PMP22 Q01453 1/20 0.44
NLRP3 Q96P20 1/20 0.44
TRPA1 O75762 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7816238 0.89 CTSK (0.45) CTSKHIF1ASMN1; SMN2SLC6A2TAAR1
Ammonia Solution, Strong SCHEMBL27796257 0.89 CTSK (0.51) CTSKHIF1ASMN1; SMN2SLC6A2TAAR1
SCHEMBL1003605 0.88 CTSK (0.49) CTSKHIF1ASMN1; SMN2SLC6A2TAAR1
SCHEMBL23016896 0.88 CTSK (0.44) CTSKHIF1ASMN1; SMN2SLC6A2TAAR1
SCHEMBL111212 0.86 ALDH1A1 (0.50) CTSKHIF1ASMN1; SMN2SLC6A2TAAR1
SCHEMBL7288405 0.85 CTSK (0.47) CTSKHIF1ASMN1; SMN2SLC6A2TAAR1
SCHEMBL3656311 0.85 SMN1; SMN2 (0.48) CTSKHIF1ASMN1; SMN2SLC6A2TAAR1
SCHEMBL872678 0.83 KCNH2 (0.51) CTSKHIF1ASMN1; SMN2SLC6A2TAAR1
SCHEMBL3833989 0.83 TSHR (0.51) CTSKHIF1ASMN1; SMN2SLC6A2TAAR1
SCHEMBL16212885 0.83 TDP1 (0.50) CTSKHIF1ASMN1; SMN2SLC6A2TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12603321-B2 Battery separators, electrodes, cells, lithium batteries and related methods CELGARD, LLC (US) 2026-04-14 US claimed
US-8383276-B2 High voltage electrolyte TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) 2013-02-26 US claimed
US-8288040-B2 High voltage electrolyte TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) 2012-10-16 US claimed
US-20110008680-A1 HIGH VOLTAGE ELECTROLYTE TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) 2011-01-13 US claimed
US-20100209780-A1 HIGH VOLTAGE ELECTROLYTE (Muldoon, Allred) TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) 2010-08-19 US claimed
US-20260149126-A1 POLYIMIDE COATED SEPARATORS, POROUS POLYIMIDE COATINGS, LITHIUM BATTERIES, AND RELATED METHODS CELGARD, LLC (US) 2026-05-28 US disclosed
US-12603321-B2 Battery separators, electrodes, cells, lithium batteries and related methods CELGARD, LLC (US) 2026-04-14 US disclosed
US-12555872-B2 Polyimide coated separators, porous polyimide coatings, lithium batteries, and related methods CELGARD, LLC 2026-02-17 US disclosed
US-20250316845-A1 COATED MICROPOROUS MEMBRANES, AND BATTERY SEPARATORS, BATTERIES, VEHICLES, AND DEVICES COMPRISING THE SAME CELGARD LLC (US) 2025-10-09 US disclosed
US-20250246760-A1 COATED MICROPOROUS MEMBRANES, AND BATTERY SEPARATORS, BATTERIES, VEHICLES, AND DEVICES COMPRISING THE SAME CELGARD LLC (US) 2025-07-31 US disclosed
US-20240329146-A1 IMPROVED BATTERIES, CELLS, COMPONENTS, AND TESTING THEREOF CELGARD, LLC 2024-10-03 US disclosed
US-20240313347-A1 IMPROVED BATTERY CELLS AND COMPONENTS THEREOF CELGARD, LLC 2024-09-19 US disclosed
CN-110168774-A Battery separator 赛尔格有限责任公司 2019-08-23 CN disclosed
US-8383276-B2 High voltage electrolyte TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) 2013-02-26 US disclosed
US-8288040-B2 High voltage electrolyte TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) 2012-10-16 US disclosed
US-20120183866-A1 Fluorinated Arylboron Oxalate as Anion Receptors and Additives for Non-Aqueous Battery Electrolytes Brookhaven Science Associates ,LLC (US) 2012-07-19 US disclosed
WO-2011031401-A2 LITHIUM NON-FLUORINATED AND FLUORINATED PHENYL TRIFLUORO BORATE SALTS FOR NON-AQUEOUS BATTERY ELECTROLYTES BROOKHAVEN SCIENCE ASSOCIATES LLC (US) 2011-03-17 WO disclosed
WO-2011014451-A2 FLUORINATED ARYLBORON OXALATE AS ANION RECEPTORS AND ADDITIVES FOR NON-AQUEOUS BATTERY ELECTROLYTES BROOKHAVEN SCIENCE ASSOCIATES LLC (US) 2011-02-03 WO disclosed
US-20110008680-A1 HIGH VOLTAGE ELECTROLYTE TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) 2011-01-13 US disclosed
US-20100209780-A1 HIGH VOLTAGE ELECTROLYTE (Muldoon, Allred) TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) 2010-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12555872-B2 Polyimide coated separators, porous polyimide coatings, lithium batteries, and related methods DCX, GABRE, DYNC1I2 CTSK 3782/4885HIF1A 4540/4885SMN1; SMN2 2075/4885
US-12603321-B2 Battery separators, electrodes, cells, lithium batteries and related methods NES, LNPK, NEK9 CTSK 313/4885HIF1A 4747/4885SMN1; SMN2 1184/4885
US-20260149126-A1 POLYIMIDE COATED SEPARATORS, POROUS POLYIMIDE COATINGS, LITHIUM BATTERIES, AND RELATED METHODS GABRE, DCX, DYNC1I2 CTSK 3806/4885HIF1A 4469/4885SMN1; SMN2 1453/4885
US-20120183866-A1 Fluorinated Arylboron Oxalate as Anion Receptors and Additives for Non-Aqueous Battery Electrolytes SLCO2B1, SLCO1B1, SLCO4C1 CTSK 2685/4885HIF1A 4832/4885SMN1; SMN2 3593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.